Evacetrapib fails to reduce major adverse cardiovascular events
Despite lowering low-density lipoprotein (LDL), known as "bad" cholesterol, while markedly increasing levels of high-density lipoprotein (HDL), or "good" cholesterol, a large clinical trial to investigate the cholesterol ...
Apr 4, 2016
0
1